HAMBURG, N.Y. -- The University of Pittsburgh at Bradford men's basketball team had a hefty second-half lead erased as the Hilbert Hawks completed a 76-70 comeback Allegheny Mountain Collegiate Conference win Wednesday.
"That's a tough one to swallow, but we need to learn to finish games," Head Coach Ryan Shay said. "We played a solid 30 minutes and then Hilbert took us out of our rhythm down the stretch."
Up 19 points early in the second half, Hilbert outscored the Panthers 49-31 in the final 20 minutes to earn its first AMCC victory of the season and improve to 1-6 in conference play. With the result, Pitt-Bradford moves to 2-5 in conference play.
Justin Kusiappouh led the Panthers in scoring with 18 points while Reggie Rogers chipped in 15 points.
Desmond Brogsdale dropped 13 points and Jeffrey Fry poured in 12 points, all of which coming on four three-pointers.
The first half belonged to the Panthers as Pitt-Bradford eventually closed out the half leading 39-27.
The Panthers shot 51.9 percent (14-27) in the first half and held the Hawks to 30 percent (9-30).
Kusiappouh erupted for 12 points in the opening half to lead the Panthers in scoring while Fry knocked down a pair of three-pointers.
But the Hawks ramped up the defensive pressure in the second half and forced 12 Panther turnovers while turning the ball over just four times themselves to climb back into contention.
Hilbert also cleaned up the glass in the second half, outrebounding Pitt-Bradford 18-9 in the period.
Foul trouble helped the Hawks mount their comeback as Pitt-Bradford was whistled for 17 second-half fouls and let the Hawks shoot 22 free throws in the half, of which they connected 20.
It was at the line that Hilbert took its first lead with 2:36 remaining. The Hawks' last eight points came at the stripe.
In all, the Panthers made eight three-pointers, half of which coming from Fry with two coming from Rogers and one apiece from Dylan Mitchell and Ugwunna Amadi.
Pitt-Bradford will be in action next on Saturday as it travels to first-place La Roche.